Search results
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance UK· 2 days agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Benzinga via Yahoo Finance UK· 3 hours agoNovo Nordisk A/S (NYSE:NVO), the maker of the popular obesity drug Ozempic, has been reprimanded by...
Everything we know about The Matrix 5
Yahoo Movies UK· 9 hours agoPacked with bold ideas and groundbreaking visual effects, The Matrix arguably altered the course of high-concept action cinema and has since become...
Second drug that slows Alzheimer's approved for use in USA
Liverpool Echo via Yahoo News UK· 3 days agoThe Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of...
Weight-loss drugs linked with lower risk of obesity-related cancers
Gulf News· 2 hours agoBlockbuster weight loss and diabetes drugs may lower patients' risk of developing some common types...
FDA approves second Alzheimer’s drug that can modestly slow disease
Irish Examiner· 2 days agoRolling coverage of the international stories of interest to our readers
FDA approves a second Alzheimer's drug that can modestly slow disease
Associated Press via Yahoo News UK· 3 days agoThe Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of...
FDA Approves Eli Lilly’s Alzheimer’s Drug Donanemab
Forbes· 4 days agoThe Food and Drug Administration on Tuesday approved donanemab for treating Alzheimer’s disease, after clinical studies indicated Eli Lilly’s drug could...
Joe Biden and Bernie Sanders Demand Drug Companies Cut Price of Ozempic and Other New Weight Loss...
Futurism via Yahoo News UK· 2 days agoIn a dual-bylined editorial, President Joe Biden and Sen. Bernie Sanders called on the makers of the...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Reuters· 4 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...